Axogen (AXGN) Cash & Current Investments (2010 - 2026)
Axogen (AXGN) recorded quarterly Cash & Current Investments of $101.6 million in Q1 2026, up 144.66% quarter-over-quarter from $41.5 million in Q4 2025, and up 360.38% on a YoY basis from $22.1 million in Q1 2025.
Axogen (AXGN) Cash & Current Investments (2010 - 2026) Analysis & Trends
Axogen's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $101.6 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 360.38% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (up 360.38% YoY), while the FY2025 annual figure was $41.5 million, up 24.03% from the prior year.
- Cash & Current Investments was $101.6 million for Q1 2026 at Axogen, up from $41.5 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $101.6 million in Q1 2026 to a low of $17.6 million in Q1 2024.
- Historically, Cash & Current Investments has averaged $40.6 million across 5 years, with a median of $34.5 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Cash & Current Investments slumped 53.43% in 2024, then surged 360.38% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $48.8 million in 2022, then sank by 36.41% to $31.0 million in 2023, then gained by 7.92% to $33.5 million in 2024, then grew by 24.03% to $41.5 million in 2025, then soared by 144.66% to $101.6 million in 2026.
- The last three Cash & Current Investments figures came in at $101.6 million (Q1 2026), $41.5 million (Q4 2025), and $35.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Axogen | 2.22 Bn | 2.12 Bn | 46.19 Mn | 101.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.60 Mn |
| Dec 31, 2025 | 41.53 Mn |
| Sep 30, 2025 | 35.79 Mn |
| Jun 30, 2025 | 29.92 Mn |
| Mar 31, 2025 | 22.07 Mn |
| Dec 31, 2024 | 33.48 Mn |
| Sep 30, 2024 | 24.53 Mn |
| Jun 30, 2024 | 21.13 Mn |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 31.02 Mn |
| Sep 30, 2023 | 32.59 Mn |
| Jun 30, 2023 | 34.53 Mn |
| Mar 31, 2023 | 37.87 Mn |
| Dec 31, 2022 | 48.79 Mn |
| Sep 30, 2022 | 53.11 Mn |
| Jun 30, 2022 | 58.03 Mn |
| Mar 31, 2022 | 67.42 Mn |
| Dec 31, 2021 | 84.09 Mn |
| Sep 30, 2021 | 91.72 Mn |
| Jun 30, 2021 | 99.92 Mn |